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resetting stimuli. Underlying these domains are differ-
ences in activatable signal transduction pathways and
dominant molecular and biochemical elements (Gillette,
1996; Gillette et al., 1995; Merrow et al., 1997). The mo-
lecular framework for these time domains is constructed
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et al., 2002).Summary
The cell cycle is another molecular timing device
found within biological systems. Similar to the circadianCircadian clocks comprise a cyclic series of dynamic
clock, the free-running period of mitosis is 24 hr incellular states, characterized by the changing avail-
many eukaryotic cells (Tyson et al., 2002). Cell replica-ability of substrates that alter clock time when acti-
tion is controlled by complex intracellular signaling path-vated. To determine whether circadian clocks, like the
ways that integrate information about the extracellularcell cycle, exhibit regulation by key phosphorylation
environment with intracellular cues. The events of theevents, we examined endogenous kinase regulation
cell cycle are predominantly controlled at the proteinof timekeeping in the mammalian suprachiasmatic nu-
level by a small number of heterodimeric protein ki-cleus (SCN). Short-term inhibition of PKG-II but not
nases. These kinases, which fluctuate over the coursePKG-I using antisense oligodeoxynucleotides de-
of the cycle, exert control over multiple proteins thatlayed rhythms of electrical activity and Bmal1 mRNA.
are involved in transcription, DNA replication, and cyto-Phase resetting was rapid and dynamic; inhibition of
kinesis by phosphorylation at specific regulatory sites,PKG-II forced repetition of the last 3.5 hr of the cycle.
rendering certain proteins active while inactivating oth-Chronic inhibition of PKG-II disrupted electrical activ-
ers (Nurse, 2002; Tyson et al., 2002).ity rhythms and tonically increased Bmal1 mRNA.
Knowledge of cell cycle regulation prompted our in-PKG-II-like immunoreactivity was detected after coim-
vestigation of critical kinases for regulating the circadianmunoprecipitation with CLOCK, and CLOCK was
clock. Clock elements are regulated by complex cellularphosphorylated in the presence of active PKG-II. PKG-
processes that include posttranslational modificationsII activation may define a critical control point for tem-
of proteins by phosphorylation (Eide et al., 2002; Gar-
poral progression into the daytime domain by acting
ceau et al., 1997; Kloss et al., 1998; Lee et al., 2001; Lin
on the positive arm of the transcriptional/translational et al., 2001; Merrow et al., 1997; Okamura et al., 2002;
feedback loop. Ripperger and Schibler, 2001). Phosphorylation of clock
elements, accomplished by specific protein kinases, is
Introduction clock state dependent (Garceau et al., 1997; Kloss et
al., 1998, 2001; Lee et al., 2001; Lowrey et al., 2000;
The periodic recurrence of night and day provides a Martinek et al., 2001; Price et al., 1995; Yang et al., 2001)
stable environmental context for life on earth. As life and characteristic of key events during clock resetting
evolved within this environment, daily biological cyclicity (Naidoo et al., 1999; Yang et al., 2001). Furthermore,
was incorporated into the genome. Thus, circadian experimental manipulation of kinase activity demon-
rhythms, or near 24 hr patterns of behavior and physiol- strates the importance of specific kinases in the regula-
ogy driven by gene expression, are nearly ubiquitous tion of the circadian timing process (Comolli and Has-
among eukaryotic organisms. Endogenous circadian tings, 1999; Eskin et al., 1984; Gillette and Mitchell, 2002;
rhythmicity is characterized by its persistence under Krucher et al., 1997; Obrietan et al., 1998; Tischkau et
al., 2000). Recently, we demonstrated clock-controlledconstant environmental conditions and its respon-
regulation of cGMP-dependent protein kinase (proteinsiveness to specific cues that enable synchronization
kinase G, PKG) activity in the SCN (Tischkau et al.,to the solar cycle. In mammals, the primary circadian
2003b). Clock sensitivity to manipulation of cGMP-clock is located within the suprachiasmatic nucleus
dependent signaling pathways is a conserved feature(SCN) of the basal hypothalamus. Although organismic
of the nocturnal domain (Eskin et al., 1984; Prosser etrhythmicity is an emergent property of the SCN, individ-
al., 1989). Activation of PKG is required during phaseual cells contain clocks (Michel et al., 1993; Welsh et al.,
resetting induced by light (Mathur et al., 1996; Weber1995). Circadian timekeeping emerges from a dynamic
et al., 1995) and glutamate (Ding et al., 1998) in the latesequence of cellular events, organized into specific time
subjective night. Inhibition of the endogenous rise indomains, which are defined by divergent sensitivities to
PKG activity at the end of subjective night causes signifi-
cant phase delays in the circadian rhythms of wheel
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dian clock at the end of the nocturnal domain. This role
would be similar to G2/M cyclin-dependent kinase (CDK)
control of progression from S phase in the cell cycle
(Hayles et al., 1994). Our results provide compelling evi-
dence for such a checkpoint at the night-to-day transi-
tion and suggest that passage through this checkpoint
is dependent upon clock-controlled activation of PKG-
II. If PKG-II activation fails to occur during this restricted
interval, the clock rapidly resets to an earlier state and
must repeat the late-night domain. Extended PKG inhibi-
tion increases in the magnitude of the delay by quantal
increments, and constant inhibition of PKG-II disrupts
SCN circadian rhythmicity. Finally, mechanistic studies
indicate that PKG may act on the positive arm of the
core molecular clockworks. Thus, increased activity of Figure 1. Isoform-Specific Antibodies Raised Against PKG-I and
PKG-II specifically at the end of subjective night is re- PKG-II Detect PKG-1 and PKG-II in SCN Tissue
quired for night-to-day progression of the SCN circa- Immunoblots were loaded with 25 g of total protein as follows (left
to right): lane 1, molecular weight standards; lane 2, HEK293 celldian cycle.
extract plus 30 ng recombinant PKG-1; lane 3, HEK293 cell extract
plus 60 ng recombinant PKG-1; lane 4, untransfected HEK293
extract; lane 5, HEK293 cells transfected with CMVneo-PKG-II; lane
Results 6, SCN tissue extract. (A) PKG-I antiserum detects a 78 kDa band
in lanes loaded with HEK cell extracts plus either 30 or 60 ng of
PKG-II in the SCN recombinant PKG-1 protein, as well as SCN extracts, but not sam-
ples of untransfected HEK cells or HEK transfected with CMVneo-PKG activity in the SCN exhibits an endogenous oscilla-
PKG-II. (B) PKG-II antiserum detects an 86 kDa band in HEK cellstion that peaks at the end of subjective night (Tischkau
that overexpress PKG-II, but not in HEK cells untransfected or con-et al., 2003b). To determine which PKG isoform(s) is
taining the recombinant PKG-I isoform. The SCN displays a band
involved in clock regulation, we developed subtype-spe- at 86 kDa that corresponds to rat PKG-II protein. The additional
cific antibodies against sequences unique to PKG-I, band at 70 kDa is an unidentified protein that was detected in
SCN extracts. HEK cells also express an 80 kDa band that is the-I, or -II. The PKG-I antibody detected a 78 kDa band
molecular weight of human PKG-II, which is expressed in kidney.corresponding to the mass of PKG-I (78 kDa) (Pohler
Labels for each blot are as follows: untransfected HEK, HEK 293et al., 1995) only in the lanes containing recombinant
cell lysate; PKG-1, bovine recombinant PKG-I in HEK cells; PKG-
PKG-I (Alexis Biochemicals, San Diego, CA) (Figure II, PKG-II overexpressed in HEK cells; SCN, SCN tissue extract.
1A). The PKG-II antibody detects a band at 80 kDa in
human embryonic kidney 293 (HEK) cell extracts corre-
Knockdown of PKG-II Resets the SCN Clocksponding to endogenous PKG-II (Figure 1B). The ex-
Pharmacological inhibition of the spontaneous rise inpression of PKG-II is expected from a cell line derived
PKG activity at the end of subjective night alters circa-
from kidney, which is known to contain high levels of
dian timekeeping (Tischkau et al., 2003b). To determine
PKG-II (Gambaryan et al., 1996; Vaandrager et al., 1997),
which isoform of PKG mediates this effect, we used
and we have determined that the HEK cell line expresses
isoform-specific antisense oligodeoxynucleotides (ODN)
significant levels of PKG-II transcript (L.A.P. and M.U.G., (Barnes et al., 2003; Tischkau et al., 2003a) directed
unpublished data). Additionally, the PKG-II antibody de- against the 5 start site of the PKG-I or PKG-II mRNA.
tects a band at the predicted 86 kDa only in the lane We examined the effects of ODN applied from circa-
loaded with PKG-II overexpressed in HEK cells. The dian time (CT) 18 to CT 23 on the electrical activity
difference in migration of this PKG-II protein is due to rhythm in SCN brain slices. In control recordings, the
the addition of a hexahistidine (Vaandrager et al., 1997) ensemble of SCN neurons displayed a spontaneous
(Figure 1B). Furthermore, Western blot analysis demon- rhythm in firing rate with a peak near CT 7 (time of peak
strated that both PKG-I and PKG-II are present in the CT 6.72  0.10, n 8) for up to 3 days when maintained
rat SCN (Figures 1A and 1B). In SCN extracts, an addi- in vitro (Figure 2A). The time of peak is an established
tional lower band corresponding to a mass of 70 kDa phase marker of the SCN circadian rhythm of electrical
was detected in the PKG-II immunoblot. This band is activity (Ding et al., 1994). Application of ODN against
also present in other rodent tissues and cell lines (un- PKG-II caused a significant phase delay of this rhythm
published data), but it is not crossreactive with antibod- (Figures 2B and 2G, mean time of peak  CT 10.13 
ies against PKG-I or PKG-I. The lower band is an 0.19 hr, n  4, p  0.01). No effect on the SCN neuronal
undetermined by-product recognized by the PKG-II- activity rhythm was observed after treatment with
specific antibody that can easily be identified by size. scrambled ODN (Figures 2C and 2G, CT 6.50  0.14,
Finally, our anti-PKG-I antibody detected a band corre- n  3) or PKG-II ODNs bearing three (Figures 2E and
sponding to the mass of PKG I (76 kDa) (Butt et al., 2G, CT 6.58  0.08, n  3) or one (Figures 2D and
1993) in a lane loaded with PKG-I recombinant protein. 2G, CT 6.67  0.22, n  3) mismatched nucleotides.
However, no band was detected in lanes loaded with Furthermore, application of PKG-I ODN had no effect
PKG-I or PKG-II protein overexpressed in the HEK cell on SCN electrical activity rhythms (Figure 2F, CT 6.42 
line or untransfected HEK cells. PKG-I was not detect- 0.17, n  3), although 6 hr treatment with PKG-I ODN
knocks PKG-1 protein levels down by 35% and func-able in SCN tissue by Western blot (data not shown).
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our contention that the lower band is not PKG-II, but an
unidentified protein that interacts with our primary an-
tibody.
Dynamic Phase Resetting by PKG Inhibition
In our system, measurable phase delays could result
from either (1) the clock stalling at the time of treatment
and remaining at that point until the treatment is re-
moved or (2) immediate clock resetting to an earlier time.
To distinguish between these possibilities, we evaluated
the effect of various durations of PKG inhibition and
effects of double pulses of inhibitors. First, the PKG
inhibitor KT5823 (1.0 M) was applied for different dura-
tions at CT 22, the time of maximal sensitivity to phase
shifting (Tischkau et al., 2003b). KT5823 was used for
these experiments rather than PKG-II ODN because
the duration of antisense treatment required for an effect
is much longer than that for KT5823 (2 hr versus 15 min).
Application of KT5823 for 0.25, 1, 2, or 3 hr beginning
at CT 22 induced 3.5 hr phase delay in the electrical
activity rhythm that was stable over two circadian cycles
(Figure 3A). However, exposure to KT5823 for 3.5 (n 3)
Figure 2. Knockdown of PKG-II by ODN Treatment from CT 19- or 6 hr (n  3), delayed the electrical activity rhythm by
23 Causes a Significant Delay in the SCN Rhythm
nearly 7 hr (6.56  0.45, 6.78  0.33, respectively,
(A) A representative single-unit recording from the ensemble of SCN Figures 3A and 3B). Therefore, the magnitude of the
neurons shows an endogenous circadian rhythm in electrical activity
phase delay was not proportional to the duration ofthat peaks at CT 7 on both day one and day two in vitro. The
KT5823 exposure. Rather, the delay occurred in whatmean time of peak for control experiments, CT 6.72  0.10 (n  8),
is the phase marker to which peak activity in experimentals was appeared to be a step function: treatments 3.5 hr in-
compared. The horizontal black bar indicates nighttime in the donor duced an 3.5 hr phase delay, while treatments 	3.5
colony; 500 m coronal hypothalamic slices were maintained in hr induced a quantal increase in the delay, from 3.5 hr
constant light. Vertical gray bars indicate the circadian time (CT) to 7 hr.
and duration of treatment.
In a second set of experiments, KT5823 was applied(B) Isoform-specific ODN against PKG-II (PKG-II, 10 M) bath
in two discrete pulses (15 min each): one at CT 22 andapplied from CT 19–23 caused a significant delay in the time of peak
for the SCN electrical activity rhythm on the subsequent day. Data a second either 1 hr later at CT 23 or 3.5 hr later at CT
shown are from a representative experiment. The average time of 1.5 (Figures 3A and 3B). A phase delay of 3.61  0.33
peak was CT 10.13  0.19 (n  4), which is significantly different (n  3) was observed when the two pulses were sepa-
from the time of peak in control recordings (p  0.01, Student’s t rated by 1 hr. In contrast, separation of the two pulses
test). This represents a mean phase delay of 3.4 hr (panel [G]).
by 3.5 hr caused a phase shift of 6.89  0.25 hr (n (C) Scrambled PKG-II ODN (10 M) had no effect on the phase of
3). Notably, these phase shifts were stable, as indicatedthe rhythm on the subsequent day. The average time of peak was
CT 6.50  0.14 (n  3), which was not significantly different from by their persistence on the third day in vitro. These data
the control time of peak (Student’s t test). are consistent with the hypothesis that phase resetting
(D) PKG-II ODN bearing one mismatched nucleotide (10 M) had is dynamic; inhibition of PKG most likely resets the clock
no effect on the phase (Student’s t test). Mean time of peak was immediately to an earlier time, from which the clock
CT 6.67  0.22 (n  3).
resumes forward progression so that it again becomes(E) PKG-II ODN bearing three mismatched nucleotides (10 M) had
sensitive to the PKG inhibition 3.5 hr later.no effect (Student’s t test). Mean time of peak was CT 6.58  0.08
(n  3). To further test the hypothesis that clock resetting is
(F) PKG-I ODN (10 M) had no effect on SCN rhythmicity (Student’s dynamic, we performed additional double-pulse experi-
t test). Mean time of peak was CT 6.42  0.17 (n  3). ments. A KT5823 pulse at CT 22 was followed by a
(G) Bar graph showing mean  SEM for these experiments (n  pulse of glutamate, which causes phase advance when
3–4). ** indicates statistical significance (p  0.01) as determined
applied in the latter half of subjective night (Ding et al.,by Student’s t test.
1994; Tischkau et al., 2000). As indicated in Figure 4A,(H) Western blot of individual SCN slices (n  3 control, 3 treated
with ODN against PKG-II) indicates a significant reduction in PKG- if phase resetting is dynamic, we predicted that a pulse
II levels after PKG-II ODN (10m) treatment from CT 1–23. Intensity of glutamate applied 30 min after the pulse of KT5823
of an uncharacterized lower band (70 kDa) is not affected by PKG- at CT 22 would cause a phase shift that corresponds
II ODN treatment. PKG-I ODN also significantly reduced PKG-I to the summation of individual phase shifts initiated first
protein levels (data not shown). Loading levels were evaluated by
by KT5823 at CT 22 (3.5 hr) and then by glutamate at CTreprobing the blot with anti--tubulin antibody.
19 (
3.5 hr); the result measured during the subsequent
circadian cycle should be no shift in clock phase. No
shift was observed when glutamate was applied 30 mintionally inactivates it (data not shown). Chronic PKG-II
ODN treatment effectively reduced the PKG-II levels following KT5823 at CT 22 (Figures 4B and 4C lane 5,
green bar, time of peakCT 6.84 0.25, n 4). Anotherin the SCN by 65% (Figure 2H). The PKG-II ODN treat-
ment did not affect expression of the lower band (70 kDa) prediction of this dynamic model is that a pulse of gluta-
mate applied 3.5 hr following a pulse of KT5823 at CTdetectable by PKG-II immunobloting, further supporting
Neuron
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To determine whether this emergence of PKG activity is
required for circadian rhythmicity, ODN to either PKG-I
or -II was applied continuously to the bath of the slice
chamber while recording SCN single-unit activity. Under
these conditions, PKG-II ODN suppressed the endoge-
nous rhythm of spontaneous electrical activity of SCN
neurons (Figure 5B, n  5). A normal rhythm was ob-
served in the presence of ODN containing an identical
complement of nucleotides in a scrambled sequence
(CT 6.53  0.25, n  4, Figure 5C) or an ODN against
PKG-I (CT 6.74  0.33, n  4, Figure 5D). We conclude
that suppression of the circadian rhythm was specific
to PKG-II ODN treatment and the concomitant reduc-
tion of PKG-II expression.
To evaluate whether the ODN-induced inhibition of
circadian rhythmicity is reversible, ODN to PKG-I or -II
was applied to SCN slices for 22 hr from CT 2 to CT 24/0.
Single-unit activity on the following day, after removal of
the treatment, revealed the reemergence of the sponta-
neous electrical activity rhythm with a peak at CT
10.19  0.16, (n  4), a phase delay of 3.47 hr (Figure
5E). These data indicate that PKG-II only, and not PKG-
I, is required for the electrical activity rhythm of SCN
neurons and that the sensitive period at the end of sub-
jective night is the only domain that is sensitive to PKG-
II inhibition. However, when PKG-II activation is blocked
during this sensitive period, either during long-term ex-
Figure 3. PKG Inhibition at the End of Subjective Night Causes posure to PKG-II ODN or by a 15 min pulse of KT5823,
Quantal Changes in the Magnitude of the Phase Shift of Electrical the delay is 3.5 hr.
Activity Rhythms in SCN Brain Slices
(A) Responses to KT5823 treatments of various durations initiated
Effects of PKG-II on Positive Clock Elements,at CT 22. Treatments of 0.25–3.0 hr caused 3.5 hr phase delays
Clock, and Bmal1in SCN electrical activity rhythms. Longer treatments, 3.5 and 6.0
hr in duration, caused 7 hr phase delays in SCN electrical activity Coimmunoprecipitation experiments were performed to
rhythms. Similarly, two treatments spanning the 3.5 hr treatment assess the potential interaction of PKG-II with the core
time caused an 7 hr phase delay. Data are mean  SEM time of clock element, CLOCK, in vivo at the end of the night.
peak neuronal activity, the phase marker, of three to six independent Western analysis of SCN extracts obtained ex vivo atsingle-unit recording experiments. Bars with different letters (a or
ZT 22 and subjected to coimmunoprecipitation with anb) indicate treatments that are statistically different from each other
antibody against CLOCK indicates PKG-II immunoreac-(p  0.01), as determined by ANOVA with Student-Neuman-Keuls
post hoc analysis. tivity (Figure 6A). PKG-II was not immunoprecipitated
(B) Phase delays stimulated by KT5823 pulses are stable. Single- with nonspecific IgG. Furthermore, CLOCK is phosphor-
unit recordings in a representative control experiment show that the ylated significantly in NIH 3T3 cells transfected with both
time of peak firing rate is the same on days 2 and 3 in vitro (top wild-type PKG-II and CLOCK. Increased phosphoryla-panel). When KT5823 was applied for either 1 hr at CT 22 of day 1
tion of CLOCK was observed in NIH 3T3 cells cotrans-(middle panel) or for 15 min at CT 22 followed by a 1 hr treatment
fected with CLOCK and a constitutively active form ofat CT 1.5 of day 2 (3.5 hr later) (lower panel), the respective 3.5 and
7 hr phase delays were stable over days 2 and 3. This indicates PKG-II (Figures 6B and 6C). Although these data were
permanent resetting of the SCN circadian clock. Dashed line, time obtained from NIH 3T3 cells and not directly from the
of peak in control SCN; arrow, magnitude of phase shift; φD, SCN, they provide evidence that CLOCK can act as a
phase delay. substrate for activated-PKG-II.
Because these data suggest an influence of PKG-II
on the positive arm of the transcriptional/translational22 should result in a phase shift measured the following
day that corresponds to the sum of effects of KT5823 negative feedback loop at the end of the night domain,
we evaluated the other element in the positive arm,at CT 22 (3.5 hr) plus a glutamate-induced shift at CT
22 (
1.5 hr); the consequent shift should be2 hr (Figure Bmal1, after PKG ODN treatment. Bmal1 mRNA levels
in 500 m SCN punches were measured by qPCR and4A). Indeed, such a phase delay (1.72 0.45 hr, n 4)
was observed when glutamate was applied 3.5 hr follow- normalized against a housekeeping transcript for acid
ribosomal protein, NM022402. Endogenous expressioning KT5823 at CT 22 (Figures 4B and 4C, lane 6, green
bar). These data strongly support the hypothesis that of Bmal1 exhibits clear circadian rhythmicity with a peak
in the latter half of night under free-running conditionsphase resetting caused by inhibiting PKG at CT 22 in-
volves a dynamic, rapid alteration in clock state so that in the SCN in vitro (Figure 7). The Bmal1 profile shows
a sharp decline in transcript abundance toward the endphase-appropriate sensitivity to glutamate reemerges.
of night. SCN slices treated with the PKG-II ODN from
CT 2 to CT 24/0 exhibited changes consistent with reset-PKG-II Is Required for SCN Circadian Rhythms
The previous experiment demonstrates that PKG-II is ting (3.5 hr) of the Bmal1 rhythm. After removal of PKG-
II ODN, Bmal1 levels in SCN were low at predicted CTrequired for progression of the circadian clock at CT 22.
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Figure 4. Double-Pulse Experiments with
KT5823 and Glutamate Indicate Rapid, Dy-
namic Phase Resetting of the SCN Clock
(A) Theoretical model depicting the phase
shifts predicted by the hypothesis that inhibi-
tion of PKG at CT 22 rapidly resets the clock
back by 3.5 hr into an earlier time domain
sensitive to phase resetting by glutamate
(GLU).
(B) Representative recordings from SCN
slices treated as indicated in the individual
panels. Blue bars indicate time of KT5823
treatment. Yellow bars indicate time of GLU
treatment. Treatment with KT5823 alone at
CT 22 caused an 3.5 hr phase delay. GLU
treatments at CT 20 caused an3.5 hr phase
advance. KT5823 followed by GLU within 30
min resulted in no change in phase on the
subsequent day. KT5823 followed by GLU
after a 3.5 hr interval caused an 2 hr
phase delay.
(C) Summary of actual phase shifts in SCN
electrical activity rhythms observed after
treatments based on the predictions made in
(A) (n  3 to 6 for each bar). Application of
KT5823 at CT 22 induces a 3.5 hr phase delay,
which predicts a rapid, dynamic phase shift
that “sets” the clock back to CT 18.5. Actual
recording data indicate that KT5823 applied
at CT 22 causes a 3.5 hr phase delay ([C1],
blue bar). Application of GLU (10 mM) at CT
19 induces a 3.5 hr phase advance, which
predicts an immediate shift of the clock for-
ward from CT 19 to CT 22.5. Single-unit re-
cordings demonstrated a 3.5 hr phase ad-
vance ([C2], yellow) in the SCN electrical
activity rhythm after GLU treatment at CT 19
(see also Ding et al., 1994; Tischkau et al.,
2000). GLU caused a 1.5 hr phase advance
when applied at CT 22.5 ([C3], yellow, also
see Ding et al., 1994). If KT5823 rapidly resets
the clock, then application of KT5823 for 15
min at CT 22 would rapidly return the clock
to CT 18.5. According to this model ([A], top),
if a 30 min period is allowed for washout of
KT5823, then GLU would actually be applied
at CT 19, which would cause a 3.5 hr phase
advance. In this case, the sum predicts that
the measured phase shift would be 0 hr. Actual recordings following this experimental treatment paradigm revealed no change in phase on
the subsequent day ([C5], green bar). Furthermore, if we would permit a longer interval to transpire before the second GLU pulse, the result
should be different. Assuming that KT5823 applied at CT 22 rapidly returns the clock to CT 18.5, following a 3.5 hr washout period, the GLU
would be applied at CT 22. This would cause an immediate 1.5 hr phase advance. The sum of these two individual shifts in clock state predicts
that the measured phase shift will be a delay of 2 hr. Actual recordings show that application of GLU at CT 22 causes a 1.5 hr phase advance
([C3], yellow bar) and the sum of this double-pulse paradigm exhibited the predicted 2 hr phase delay ([C6], green bar). Data are mean 
SEM of three to six independent experiments.
0 or after the decline in late night and were significantly jective night and that the Bmal1 oscillation proceeds
from this point after ODN removal.reduced at predicted CT 5 compared to control samples
treated with PKG-I ODN (Figure 7A). This change is
consistent with the phase-resetting effects of PKG-II Discussion
ODN on the electrical activity rhythm (Figure 2).
Similar results were observed in SCN slices treated Our results define a critical, dynamic domain of kinase
control within the circadian cycle. Whereas our initialcontinuously with PKG-II ODN and collected at CT 23,
0, and 4 as well as at CT 21 on the following day (after study suggested a role for PKG at the end of the night,
the data presented in this manuscript move well beyond44 hr in vitro) (Figure 7B). PKG-II ODN treatment signifi-
cantly altered Bmal1 levels in samples obtained at CT that study to provide a specific, essential mechanism
for the regulation of endogenous clock function by PKG-23 and on the following day at CT 21. These observations
are consistent with the hypothesis that the rhythm is II. The data indicate that progression of the circadian
cycle, at the levels of both core clock elements anddisrupted by PKG-II ODN treatment, so that Bmal1
cycles repeatedly through the 3.5 hr period where en- the endogenous SCN neuronal activity rhythm, requires
activation of PKG-II by intrinsic clock mechanisms. Be-dogenous levels change significantly at the end of sub-
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Figure 5. Continuous Inhibition of PKG-II Using ODN Disrupts the
Electrical Activity Rhythm of the SCN, whereas 22 Hr Inhibition
Causes Phase Delay
The horizontal black bar indicates nighttime in the donor colony; 500
m coronal slices were maintained in constant light. Gray shading
indicates the time and duration of treatment. Slices were prepared
between ZT 0.5 and ZT 2. Treatment began at CT 1 in continuous
ODN experiments (B and C) and at CT 2 for long-term treatments.
Figure 6. CLOCK Is a Potential Substrate for PKG-II(A) A representative single-unit recording from the ensemble of SCN
neurons shows an endogenous electrical activity rhythm with a peak (A) SCN extracts were obtained directly from the animal at ZT 22
at CT 7 on both day two and day three in vitro. Mean time of peak and subjected to immunoprecipitation by anti-CLOCK antibody.
for control experiments (n  8) was CT 6.88  0.11; this value Western analysis of immunoprecipitates demonstrates an appropri-
is the phase marker to which experimentals were compared. (B) ately-sized band corresponding to PKG-II, suggesting an associa-
Continuous application of PKG-II ODN disrupted the SCN electrical tion between CLOCK and PKG-II in the SCN in vivo. Lane 1, PKG-
activity rhythm on days two and three in vitro. Data were collected II immunoreactivity by Western blot of SCN extract; lane 2, IgG
from a second slice on the second day of recording (indicated by control; lane 3, PKG-II Western blot of CLOCK coimmunoprecipitate.
the // in the record). Data are representative of five independent Data are representative of four independent experiments.
experiments. (C) Continuous application of a scrambled PKG-II (B) Phosphorylation of CLOCK in NIH 3T3 cells cotransfected with
ODN had no effect on the timing of the SCN electrical activity wild-type or constitutively active PKG mutant. After incubation with
rhythm. Data are representative of four independent experiments. 200 Ci/ml 32PO4i for 5 hr, cell extracts were immunoprecipitated
(D) Long-term application of a PKG-I ODN for 22 hr had no effect with anti-CLOCK antibody and then split 1:3. Twenty-five percent
on the timing of the SCN electrical activity rhythm. Data are repre- was run on a gel for Western analysis of heavy chain as a control
sentative of four independent experiments. (E) Long-term applica- for immunoprecipitation and loading (bottom panel). Seventy-five
tion of PKG-II ODN for 22 hr caused a 3 hr phase delay in SCN percent was separated by SDS-PAGE and incorporated 32PO4i was
activity rhythms. Data are representative of four independent experi- determined by autoradiography. The blot is representative of
ments. Mean time of peak was CT 10.19 0.16, which is significantly three experiments.
different from controls (p  0.01, Student’s t test). (F) Bar graph (C) Quantitation of (B). Densitometric analysis of autoradiographs
showing mean  SEM for these experiments (n  3–4). ** indicates demonstrates that CLOCK shows phosphorylation when cells are
statistical significance (p  0.01) as determined by Student’s t test. cotransfected with wild-type PKG-II. CLOCK phosphorylation is in-
creased when cells are cotransfected with a constitutively active
PKG-II mutant. Data represent mean  SEM for three experiments.
cause clock-controlled phosphorylation events regulate *** indicates statistical significance (p  0.001) between indicated
pairs as determined by Student’s t test.core clock components (Eide et al., 2002; Garceau et
al., 1997; Kloss et al., 1998, 2001; Lee et al., 2001; Lin
et al., 2001; Lowrey et al., 2000; Martinek et al., 2001;
Merrow et al., 1997; Myers et al., 1996; Okamura et al., kinase, defines its regulatory influence as a narrow tem-
poral domain at the end of the nighttime, and suggests2002; Ripperger and Schibler, 2001; Zeng et al., 1994),
understanding the actions of specific protein kinases that it acts on the positive arm of the core clockwork.
Brief inhibition of the endogenous rise in PKG activitywithin defined time domains is likely to provide funda-
mental insights into clock organization. (Tischkau et al., 2003b) causes quantal delays in SCN
circadian rhythms (Figure 3). Long-term knockdown ofThis study identifies PKG-II as an important regulator
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Figure 7. Inhibition of PKG-II Alters the Cir-
cadian Rhythm of Bmal1 mRNA
The endogenous circadian profile of Bmal1
was determined by qPCR of 500 m reduced
SCN brain slices (n  3 for each time point,
data double plotted). Shaded bars mark the
time of ODN treatment. (A) Effect of 22 hr
ODN treatment, followed by release. Small
gray circles indicate Bmal1 levels relative to
acidic ribosomal protein mRNA in control
SCN slices collected at the reported time
points. The endogenous Bmal1 rhythm
peaked at CT 19, rapidly declined by CT 21
to a trough between CT 0–3, then increased
markedly by CT 7. PKG-I or PKG-II ODN (10
M) was applied for 22 hr, from CT 2 on day
1 in vitro to CT 24/0. SCN slices were collected 0 and 5 hr after release from ODN treatment. The Bmal1 expression profile was not altered
by PKG-I ODN (large black circles). PKG-II ODN significantly reduced Bmal1 levels (open squares) at predicted CT 5 compared to PKG-I
ODN. These levels would be expected if the clock were delayed 3.5 hr by the PKG-II ODN treatment. Arrows point to the values expected
if relative expression of the Bmal1 transcript were delayed 3.5 hr by the PKG-II ODN treatment. (B) Effect of continuous PKG-II ODN
treatment throughout a 44 hr experiment until the slices were collected. This treatment is predicted to maintain the clock in a continuous 3.5
hr loop encompassing the end of night (also see Figures 3 and 8). Yoked control slices were maintained under parallel conditions, omitting
ODN. Bmal1 levels in yoked controls (large gray circles) are comparable to those measured over the first cycle in vitro. Levels under PKG-
II ODN treatment (open squares) are significantly different at CT 23 and on the second day at CT 21 (after 44 hr in vitro) and match levels
predicted if the clock is repeatedly delayed by 3.5 hr at the end of subjective night. Tables present the relative expression levels of the Bmal1
transcript. # indicates that the SCN slice was in vitro for 44 hr; ** indicates statistical significance (p  0.05, Student’s t test) compared to
time-matched controls.
PKG-II leads to arrhythmicity in electrical activity (Figure transited 3.5 hr later (Figure 8). We predict that stimuli
that cause this phase advance prematurely trigger5). Without PKG-II, the clock behaves as if locked in a
dynamic loop that encompasses the biochemical state events that would be activated endogenously within the
clock at this later time. In concordance with this predic-of late night. By potentially interacting with CLOCK dur-
ing its phosphorylation, PKG-II may influence core clock tion, we demonstrated clock-controlled elevation of
cGMP levels and PKG activity at CT 24/0 (Tischkau etcomponents to signal the completion of nighttime pro-
cesses and permit transit to the daytime domain. Thus, al., 2003b); increased expression of PKG-II at this time is
likely a major contributor to this increase in PKG activityclock-controlled activation of PKG-II may serve as a
critical checkpoint of temporal state at the night-to-day (Ferreyra and Golombek, 2001).
transition, which would align with dawn in the solar
cycle.
Pharmacological studies have established a role for
the cGMP/PKG signal transduction cascade activated
by light/glutamate in phase resetting of the circadian
clock during the second half of night (Ding et al., 1998;
Liu et al., 1997; Mathur et al., 1996; Prosser et al., 1989;
Weber et al., 1995). Glutamate application to SCN slices
raises cGMP levels and activates PKG (S.A.T. and
M.U.G., unpublished data) only when glutamate causes
phase advance of the circadian clock. Inhibition of PKG
activity blocks light- (Mathur et al., 1996; Weber et al.,
1995) and glutamate-induced (Ding et al., 1998) phase
advances in the late night but has no effect on light- or
glutamate-induced phase delay in early night (Ding et
Figure 8. Model of Circadian Clock Regulation by cGMP/PKG atal., 1998).
the End of Subjective NightClock phase is advanced if the marker of clock phase
The SCN is sensitive to phase resetting by stimuli that raise cGMPoccurs earlier on the cycle(s) following a stimulus (e.g.,
and activate PKG during the last half of subjective night. Whenonset of wheel running, peak electrical activity, peak
phase shifts are modeled as rapid, dynamic state changes, theseexpression of Per1) than on preceding cycles. Treat-
stimuli would quickly set the clock forward several hours to the end
ments that cause phase advance could be considered of night. The rising phases of endogenous oscillations in cGMP
to have temporarily shortened tau, the period of the levels and PKG activity are coincident with the waning of sensitivity
to phase resetting by cGMP/PKG-dependent mechanisms. Inhibi-clock; the amount of reduction is equivalent to the phase
tion of PKG activity during the time of the endogenous activationadvance. In the case of a glutamate-induced phase ad-
shifts the clock backward in the circadian cycle, into the domain ofvance of neuronal activity rhythms, the phase advance
sensitivity to phase resetting by stimuli that activate cGMP/PKGis 3.5 hr. Thus, tau on that day is 20.5 hr instead
(light/GLU). Thus, the endogenous rise in cGMP/PKG activity at the
of the normal 24 hr, as that cycle has lost 3.5 hr. We end of the night may act as a critical clock control point, signaling
hypothesized that this phase-advancing stimulus termination of nighttime processes and/or initiating the events that
mediate temporal progression into the day.caused the clock to jump ahead to a state normally
Neuron
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Endogenous activation of PKG is critical in regulating shown), suggesting that the regulation of this check-
clock timing. Inhibition of the clock-controlled increase point by PKG-II may affect multiple clock elements in
in PKG activity causes significant phase delay of the addition to Bmal1. We predict that continual exposure
circadian rhythm (Figure 2) (Tischkau et al., 2003b). to the PKG-II ODN deprives the clock from executing
Phase delay may be interpreted as an event that causes a critical temporal event and thus results in persistent
a transient lengthening of tau. There are two plausible repetition of the 3.5 hr preceding the transition to day.
explanations for lengthening of tau. First, the clock could Because the clock cannot progress without PKG-II,
simply be stopped for the duration of treatment. These clock state remains trapped in the nocturnal domain
circumstances would predict that the amplitude of and rhythmicity is disrupted. Similarly, G2/M CDK inhibi-
phase delay would be proportional to the length of treat- tion or Cdc13p G2/M cyclin deletion causes repeated
ment. Second, the phase-delaying stimulus could actu- rounds of mitotic S phase to occur (Hayles et al., 1994;
ally move clock state back in time, positioning it to re- Moreno and Nurse, 1994). Thus, just as activation of
peat a portion of the circadian cycle. Under these G2/M CDK provides checkpoint control of the cell cycle
circumstances, the phase delay would equal the number by signaling successful completion of S phase, PKG-II
of hours the clock is forced to repeat. Our data are may exert checkpoint control over the circadian cycle
consistent with the second hypothesis. Phase delays by signaling the completion of nighttime processes.
induced by inhibition of endogenous PKG activity are Temporal restriction of PKG-II activation and the re-
not proportional to the time of treatment; rather, they quirement of PKG-II by the clock at the end of the night
appear as quantal increments of 3.5 hr. Inhibition for raise questions about the nature of the substrates on
0.25, 1, 2, or 3 hr caused the same 3.5 hr phase delay which it acts. In Drosophila, the progressive increase in
(Figures 3C and 3D), whereas inhibition for 3.5, 6 hr, apparent molecular weights of clock gene products,
or two pulses separated by 3.5 hr doubled this effect, PER (Kloss et al., 2001; Lowrey et al., 2000; Zeng et
delaying the electrical activity rhythm by nearly 7 hr. al., 1994) and TIM (Myers et al., 1996), which occurs
Because PKG inhibition with ODN reduces PKG-II pro- throughout the last half of the night, suggests that these
tein (Figure 2H), the delay likely represents the time proteins are phosphorylated prior to their degradation
required to resynthesize PKG-II to a level that would at the end of the night. Furthermore, FRQ, the protein
reinstate the checkpoint required for the night-to-day product of the Neurospora clock gene frequency, under-
transition. Preliminary studies indicate that PKG-II re- goes similar phosphorylation events during the circa-
emerges within 2 hr following cessation of treatment dian cycle (Garceau et al., 1997). Evaluation of specific
with the PKG-II ODN (J.W.M. and M.U.G., unpublished functional roles for kinases that mediate clock-con-
data). Because PKG-I ODN does not alter rhythms at trolled phosphorylation of SCN clock components (Eide
this time, the end of night regulatory role is mediated et al., 2002; Martinek et al., 2001) is limited. However, the
by PKG-II. clock-controlled nature of these phosphorylation events
If PKG inhibition at CT 22 actually resets the clock to raises the intriguing possibility that temporally restricted
an earlier state (CT 18.5), as predicted by our model spheres of kinase influence, such as those described in
(Figure 8), the clock should again be sensitive to the this report, may mediate posttranslational effects on
phase-advancing effect of glutamate immediately upon proteins critical to clock timing. We present data sug-
conclusion of treatment. When PKG inhibition at CT 22 gesting that PKG-II may influence rhythmicity by acting
was followed 30 min later by glutamate stimulation, the on the positive arm of the molecular clockwork. Coim-
SCN neuronal activity rhythm peaked at CT 7 on the munoprecipitation studies from SCN extracts indicated
following day. These data are consistent with the sum- that PKG-II-like immunoreactivity was present after im-
mation of a phase delay induced by PKG inhibition at CT munoprecipitation with CLOCK. When cotransfected
22 followed by a phase advance induced by glutamate at with PKG-II into NIH 3T3 cells, CLOCK showed in-
CT 19. When PKG inhibition at CT 22 was followed 3.5 hr
creased phosphorylation that reflected relative PKG-II
later by a glutamate stimulus, the SCN neuronal activity
activity. In addition, PKG-II-driven transcription could
rhythm peaked at CT 8.5 on the subsequent day. This
initiate early morning accumulation of clock gene mRNAsphase delay is consistent with summation of an 3.5
(Panda et al., 2002), although we have not yet testedhr phase delay induced by PKG inhibition at CT 22 and
this idea. The extent to which these phosphorylationan 2.0 hr phase advance stimulated by glutamate at
events serve as critical checkpoints paralleling the regu-CT 22. We conclude that inhibition of PKG at the end
latory roles at transition points controlling timing andof subjective night rapidly returns the clock to a state
progression of cell cycle clocks (Bell and Dutta, 2002;previously transited 3.5 hr earlier (Figure 8). The return
Gitig and Koff, 2001; Yew, 2001) remains an area ofto this state permits reemergence of PKG-II activity and
active investigation.immediate procession of timekeeping.
Continuous exposure to ODN directed against PKG-
II led to arrhythmicity of the SCN electrical activity Experimental Procedures
rhythm (Figure 5). Short-term treatment with PKG inhibi-
Animals and Circadian Timetors or PKG-II ODN at the end of subjective night forces
Six- to twelve-week old LE/BluGill rats (University of Illinois) wererepetition of the preceding 3.5 hr, during which PKG-II
used for these studies. Use of this inbred strain greatly reducesfunction is restored. Analysis of Bmal1 mRNA levels
interexperimental variation common to outbred animals and allows
(Figure 7) after ODN indicates that PKG-II ODN can the achievement of high statistical significance with small sample
alter a core clock element at the end of the nocturnal sizes. A dense genome scan was performed at a 10 cM interval
domain. In preliminary studies, we have seen similar between markers on our LE/BluGill progenitors. The results of this
scan, performed by the Medical College of Wisconsin Human andeffects of PKG-II ODN on Per1 expression (data not
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Molecular Genetics Center as part of the National Heart, Lung, and dian times were frozen on dry ice and maintained at 80C until
analysis. Slices were homogenized in 50 l ice-cold T-PER (Pierce)Blood Institute (NHLBI) Programs for Genomic Applications (PGA)
U01 HL66579, demonstrated that the colony is inbred, yielding one containing Complete Protease Inhibitor Cocktail (PI, Roche) and
phosphatase inhibitors (Phosphatase Inhibitor Set I&II, Upstate Bio-allele at each locus tested (http://pga.mcw.edu/pga-bin/strain_
desc.cgi). technology) by repeat pipetting. Protein content was determined
with the Micro BCA Protein Assay (Pierce). Total protein (12.5–25Rats were provided food and water ad libitum and were housed
under a 12:12 hr light/dark (LD) schedule; ZT 0 is defined as the g) was resolved by 4%–15% gradient SDS-PAGE and transferred
to nitrocellulose membrane. Blots were probed with PKG-I (1:1000),time of lights on in animal colony. For SCN slices maintained under
constant conditions of the brain slice chamber, circadian time (CT) PKG-I (10 g/ml), or PKG-II (1:250) antiserum followed by goat
anti-rabbit HRP-linked secondary antibodies (1:5000, Chemicon).is reckoned from the lighting schedule in the donor colony.
Blots were reprobed for -tubulin as a loading control. Blots were
developed with Supersignal chemiluminescent substrate (Pierce,Preparation and Treatment of Brain Slices
Rockford, IL). Digital photography and quantitation was performedCoronal brain slices (500 m) were prepared at least 2 hr prior to
with the Biochemi Analysis system (UVP).the onset of the dark phase of the LD cycle to avoid phase shifts
during preparation (Prosser et al., 1989; Prosser and Gillette, 1989).
Slices containing the paired SCN were studied for up to 3 days Single-Unit Recordings of SCN Neuronal Activity
in vitro with continuous perfusion of Earle’s Essential Balanced Salt The effects of stimuli on the rhythmicity or phasing of SCN slices
Solution (EBSS, Life Technologies, Gaithersburg, MD), supple- were assessed in vitro using the standard extracellular single-unit
mented with 24.6 mM glucose, 26.2 mM NaHCO3, and 2.5 mg/L recording technique (Prosser et al., 1989; Prosser and Gillette, 1989).
gentamicin and saturated with 95% O2/5% CO2 at 37C (pH 7.25). Spontaneous firing rates of individual neurons were grouped into
Under these conditions, the SCN generates stable, near 24 hr oscilla- 2 hr running averages using 15 min lags. The time of peak for each
tions in neuronal activity with a characteristic peak around mid-day experiment was determined by visual inspection of a plot of 2 hr
(CT 7) (Gillette and Prosser, 1988); measurement of time of peak running averages for the symmetrically highest point. A characteris-
provides an accurate assessment of circadian phase (Gillette et al., tic pattern of change, such that activity was low during subjective
1995). Treatments were applied to the bath of the brain slice cham- night and peaked mid-day near circadian time 7 (CT 7, 7 hr after
ber under static bath conditions. Treatments included the specific the onset of light in the donor colony), was observed in vehicle-
PKG inhibitor, KT5823 (1.0 M), or ODNs (10 M) designed to treated control slices. Phase shift or, in some cases, the presence
test for PKG specificity. For continuous ODN treatment, media or absence of a rhythm was determined by comparing the mean
containing ODN was continuously perfused through the chamber, time of peak from treatment groups to vehicle-treated controls.
and the flow rate was reduced to 2 ml/hr. Treatment times ranged Certain recordings were performed with the experimenter blind to
from 0.25 to 58 hr. the treatment conditions.
Isoform-Specific PKG Antisera Quantitative Real-Time RT-PCR
Polyclonal antisera were raised in rabbit to synthetic peptides cho- Single 500m SCN reduced slices were collected on dry ice immedi-
sen to confer specificity and antigenicity for each PKG isoform. ately after treatment. Samples were placed in 1 ml TRIzol reagent
Antisera were generated against the following peptide encoding (GIBCO BRL/Invitrogen, Carsbad, CA). RNA isolation was performed
residues: PKG-1, 51-78 of human PKG-I (accession number according to the manufacturer’s protocol. Concentration and purity
D45864); PKG-I, 51-76 of human PKG-I (accession number S05702); of the RNA was determined by UV spectrophotometry. Reverse
and PKG-II, 1-29 of rat PKG-II (accession number CAA85284). Pep- transcription was performed in duplicate with 500 ng of total RNA
tides were synthesized at the Protein Sciences Facility (University in a volume of 10 l, and 200 ng of random hexamers were added.
of Illinois Biotechnology Center). Isoform specificity was confirmed Samples were heat denatured at 75C for 10 min and quick chilled on
by testing the immunoreactivity of each antiserum to all three PKG ice to minimize secondary structure present in the RNA. Invitrogen
isoforms. PKG-I (bovine, recombinant Spodoptera frugiperda) was Superscript II reverse transcriptase (200 U) was added along with
purchased from Calbiochem (San Diego, CA). PKG-I (bovine, re- buffer and 500 M dNTP mix (final reaction concentration) to bring
combinant baculovirus) was purchased from Alexis Biochemicals the total sample volume to 20 l. Reactions were incubated for 1 hr
(San Diego, CA). pCMVneo PKG-II cDNA (a gift from Dr. Michael at 42C followed by a 10 min deactivation at 92C. Samples were
Uhler, University of Michigan) was overexpressed in HEK cells by then diluted to 100 l with nuclease-free water and stored at 20C
transient transfection using Mirus trans-it LTI transfection reagent until use.
(Madison, WI) according to the manufacturer’s instructions. Addi- Primers were chosen using Primer Express 2.0 software (Applied
tionally, specific tissues known to express or not express PKG iso- Biosystems, Foster City, CA). A BLASTN search was then performed
forms were used to verify the isoform specificity of our antisera against GenBank to ensure that all primers were unique to the gene
(data not shown). Finally, preabsorption with the synthetic peptide of interest. To avoid amplification from genomic DNA contamination,
against which each antibody was generated resulted in the loss of primer sets were designed to amplify across an intron/exon junction.
the band for each respective PKG band (data not shown). Bmal1 primers were as follows: forward, TCTATCCGATGACGAACT
GAAACA; reverse, CCCTCGGTCACATCCTACGA. Acidic robosomal
Isoform-Specific ODNs protein PO (accession number NM022402) primers were as follows:
Isoform-specific ODNs were designed to distinguish between forward, CGTGATGCCCAGGGAAGA; reverse, TCCCACAATGAAG
PKG-II (5-CCATGTTGCTCAGGA-3) and PKG-I (5-CCCATGCTCC CATTTTGG.
TCCGG-3). The ODN for PKG-I would affect both PKG-I and All reactions were performed on the BioRad iCycler in triplicate
PKG-I; however, PKG1 is not detectable in the SCN (data not with 12.5 l SYBR Green Master Mix (Applied Biosystems, Foster
shown). In addition, PKG-II-specific ODN containing one (5-CGAT City, CA), 300 nM forward and reverse primer final concentration,
GTTGCTCAGGA-3) or three (5-CGATGATGCTCACGA-3) mis- 5 l of diluted RT reaction, and water to a final reaction volume of
matched nucleotides or scrambled sequence (5-TCAGTACTGAG 25 l. Initial denature was carried out at 95C for 10 min, followed
GCCT-3) were generated for use as controls. by 50 cycles of 15 s at 95C and 15 s at 60C. Heat disassociation
was performed to check for nonspecific signals from SYBR Green
and to ensure amplification specificity.Western Blot
Hypothalamic brain slices (500 M) containing the paired SCN were qPCR results are represented as a ratio of relative expression
levels of the transcript of interest compared to a housekeepingtrimmed under a dissecting scope to preserve only the SCN and
underlying optic chiasm. These “reduced” slices retain the electro- transcript (acidic ribosomal protein, NM022402) used as a loading
control and normalized to the value at CT 0. Relative expressionphysiological and biochemical properties observed in full-size SCN
slices (Gillette and Reppert, 1987). Slices were equilibrated in the levels were determined by comparing the cycle at which an arbitrary
fluorescent threshold (Ct value) was reached to a standard curve forbrain slice chamber for at least 2 hr before the initiation of sample
collection. Slices removed from the chamber at appropriate circa- each primer set based on known RNA concentration, as described
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previously (Bustin, 2000). The Ct value for a particular gene of inter- Bell, S.P., and Dutta, A. (2002). DNA replication in eukaryotic cells.
est was considered to be a general indicator of transcript level; Annu. Rev. Biochem. 71, 333–374.
threshold was placed at a value that was in the exponential portion Bustin, S.A. (2000). Absolute quantification of mRNA using real-
of the amplification plot for all the products being generated and time reverse transcription polymerase chain reaction assays. J. Mol.
was held constant for all runs. Endocrinol. 25, 169–193.
Butt, E., Geiger, J., Jarchau, T., Lohmann, S.M., and Walter, U.Coimmunoprecipitation
(1993). The cGMP-dependent protein kinase—gene, protein, andSingle paired SCN (400 m) were collected directly from animals
function. Neurochem. Res. 18, 27–42.sacrificed under red light at ZT 22 and frozen immediately on dry
Comolli, J., and Hastings, J.W. (1999). Novel effects on the Gonyau-ice. Ice-cold T-PER with protease inhibitors and phosphatase inhibi-
lax circadian system produced by the protein kinase inhibitor stauro-tors (PI/PhI, 100 l) was added to each microfuge tube containing
sporine. J. Biol. Rhythms 14, 11–19.a SCN slice. The tube or plate was set on ice for 2 min. Slices were
lysed by repeat pipetting and samples centrifuged at 10,000 RPM Ding, J.M., Chen, D., Weber, E.T., Faiman, L.E., Rea, M.A., and
for 5 min at 4C. The protein supernatant was then transferred to a Gillette, M.U. (1994). Resetting the biological clock: mediation of
new chilled microfuge tube and protein concentration derived as nocturnal circadian shifts by glutamate and NO. Science 266, 1713–
described above. Total protein (150 g) was brought to a total vol- 1717.
ume of 500 l in T-PER with PI/PhI. Protein G Sepharose (20 l of Ding, J.M., Buchanan, G.F., Tischkau, S.A., Chen, D., Kuriashkina,
50% slurry, Pharmacia/Amersham, Piscataway, NJ) in T-PER with L., Faiman, L.E., Alster, J.M., McPherson, P.S., Campbell, K.P., and
PI/PhI was added to each Co-IP sample. Antiserum (1 g) was Gillette, M.U. (1998). A neuronal ryanodine receptor mediates light-
added to each sample. Each Co-IP was performed with the antibody induced phase delays of the circadian clock. Nature 394, 381–384.
of interest and an isotype control antibody to evaluate nonspecific
Eide, E.J., Vielhaber, E.L., Hinz, W.A., and Virshup, D.M. (2002).interactions. Samples were gently rotated overnight at 4C and were
The circadian regulatory proteins BMAL1 and cryptochromes arewashed three times with T-PER with PI/PhI. Laemmli’s Buffer (30
substrates of casein kinase I epsilon. J. Biol. Chem. 277, 17248–l) was added and samples were heated at 100C for 5 min and
17254.centrifuged at 14,000 RPM for 10 min. Co-IP samples along with a
lysate control from the same SCN slice were resolved on a 4%–15% Eskin, A., Takahashi, J.S., Zatz, M., and Block, G.D. (1984). Cyclic
SDS-PAGE gel and blotted as outlined above for the antibody of in- guanosine 3:5-monophosphate mimics the effects of light on a
terest. circadian pacemaker in the eye of Aplysia. J. Neurosci. 4, 2466–2471.
Ferreyra, G., and Golombek, D.A. (2001). Rhythmicity of the cGMP-
In Vivo Phosphorylation related signal transduction pathway in the mammalian circadian
NIH 3T3 cells were transfected according to the manufacturer’s system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1348–
instructions with JetPEI (Qbiogene, Carlsbad, CA) with the mCLOCK R1355.
pCDNA expression vector (kindly provided by Dr. C. Weitz, Harvard
Gambaryan, S., Hausler, C., Markert, T., Pohler, D., Jarchau, T.,University) and expression vectors encoding either wild-type PKG-
Walter, U., Haase, W., Kurtz, A., and Lohmann, S.M. (1996). Expres-II or a PKG-II constitutively active mutant (R118A/R119A/V125A), as
sion of type II cGMP-dependent protein kinase in rat kidney is regu-indicated (PKG expression vectors kindly provided by Dr. M. Uhler,
lated by dehydration and correlated with renin gene expression. J.University of Michigan). The levels of DNA used in transfections
Clin. Invest. 98, 662–670.were kept constant using empty control vector. Forty hours after
transfection, cells were transferred for 1 hr to phosphate-free EMEM Garceau, N.Y., Liu, Y., Loros, J.J., and Dunlap, J.C. (1997). Alterna-
and then incubated with 200 Ci/ml 32PO4i (Perkin Elmer, Boston, tive initiation of translation and time-specific phosphorylation yield
MA) for 5 hr at 37C. Cells were subjected to lysis and Co-IP with multiple forms of the essential clock protein FREQUENCY. Cell
mCLOCK-specific antiserum. Washed mCLOCK immunoprecipi- 89, 469–476.
tates were eluted in Laemmli’s buffer and split 1:3. Twenty-five per- Gillette, M.U. (1996). Regulation of entrainment pathways by the
cent of the eluted protein was used for Western analysis of heavy suprachiasmatic circadian clock: sensitivites to second messen-
chain (loading and Co-IP control), and the other 75% was separated gers. Prog. Brain Res. 111, 121–132.
by SDS-PAGE and analyzed after autoradiography (32P incorpo-
Gillette, M.U., and Mitchell, J.W. (2002). Signaling in the suprachias-ration).
matic nucleus: selectively responsive and integrative. Cell Tissue
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